Which of the following is done for a patient on coumarin (warfarin) therapy:
**Core Concept**
Warfarin, a coumarin anticoagulant, works by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver, thereby prolonging the prothrombin time (PT) and international normalized ratio (INR). This mechanism is crucial for understanding the management of patients on warfarin therapy.
**Why the Correct Answer is Right**
Patients on warfarin therapy require regular monitoring of their INR to ensure it falls within the therapeutic range (usually 2.0-3.0). If the INR is too low (subtherapeutic), the risk of thrombosis increases, while an INR that is too high (supratherapeutic) increases the risk of bleeding. Therefore, frequent INR testing is essential to adjust warfarin doses and prevent adverse outcomes.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to warfarin therapy. While patients on warfarin should be aware of potential drug interactions, this statement does not address the specific management of warfarin therapy.
* **Option B:** Vitamin K is not administered to patients on warfarin therapy for routine management. However, vitamin K is used to reverse warfarin anticoagulation in emergency situations, such as before surgery.
* **Option C:** While it is essential to monitor patients on warfarin therapy, this option does not specifically address the need for regular INR testing.
**Clinical Pearl / High-Yield Fact**
Warfarin therapy requires a narrow therapeutic window, and even small changes in INR can have significant consequences. It is essential for patients on warfarin to maintain a consistent diet, avoid excessive consumption of vitamin K-rich foods, and report any changes in medications or symptoms to their healthcare provider.
**Correct Answer: C. Regular INR monitoring**